arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

BOSTON SCIENTIFIC CORP

BSX
$49.32 ▲ +0.05 (+0.09%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
20 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
76
Health
Good
Neutral
auto_awesome

Analytical Summary

BOSTON SCIENTIFIC CORP shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $73.0B
Dividend Yield
Revenue Growth 19.9%
Op. Margin 18.0%
ROIC 12.7%
FCF / Share $2.47
Trailing P/E 25.2x
Price / Book 3.0x
FCF Yield 5.0%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

20-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$20.07B
↑ +19.9%
Net Income Profit after all expenses
$2.89B
↑ +56.7%
Operating Margin Operating profit as % of sales
18.0%
↑ +15.8% 72th
FCF / Share Free cash flow per share
$2.47
↑ +37.5%
Long-Term Debt Long-term obligations
$3.81B
↓ -29.4%

Health Breakdown

Profitability
75
Returns
73
Financial Health
83
Cash Quality
75

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 74 quarters